The FDA recently approved a bioengineered blood vessel, which becomes part of a patient’s body over time. It’s designed to ...

DURHAM, N.C. - Humacyte, Inc. (NASDAQ:HUMA), a biotechnology firm specializing in bioengineered human tissues with a current market capitalization of $580 million, and Pluristyx, Inc., a provider of ...

Pluristyx has developed a clinical-grade manufacturing process for using a licensed Mad7 gene editing technology to block Human Leukocyte Antigen (HLA) markers expression. Humacyte is optimizing a ...

Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissue ...

The clinical trial will compare Humacyl to the current standard of care, synthetic grafts made from expanded polytetrafluoroethylene ... The trial is the largest study of any bioengineered vascular ...

Laura Loomer, a close ally of President Donald Trump and a far-right activist, asked the president to intervene as she continues to accuse billionaire Elon Musk of censoring her account on X.

Laura Caron, 34, was freed after a detention hearing Tuesday, according to the Cape May County Prosecutor's Office. Caron had been held in Cape May County Jail since Wednesday, Jan. 15 ...

The Queen returned to the hospital where she gave birth to her daughter, Laura Lopes, as she revealed her grandchildren were "regular visitors" to its A&E department. Camilla, 77, opened the new ...

The sdATEV, a bioengineered human tissue designed to be universally implantable, has previously been studied in a 6.0mm configuration for vascular trauma repair ... reducing the size mismatch with ...

This innovation could provide a much-needed off-the-shelf alternative to traditional grafts, potentially improving ... of the sdATEV in CABG," said Laura Niklason, Founder and CEO of Humacyte.